Tags
cartilage defects
Specialties
Regenerative Medicine
10 results found in 2ms
  • ‹‹
  • 1
  • ››
ChondroFiller injection safety: what the evidence showsChondroFiller injection safety: what the evidence shows
Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).
ChondroFiller injection for hip cartilage defectsChondroFiller injection for hip cartilage defects
ChondroFiller is an injectable collagen scaffold that repairs hip cartilage by recruiting the body's own repair cells; delivered under local anaesthesia as an outpatient procedure, it shows 70–85% symptom relief in small published series, though long-term data beyond five years are absent.ChondroFiller is an injectable collagen scaffold that repairs hip cartilage by recruiting the body's own repair cells; delivered under local anaesthesia as an outpatient procedure, it shows 70–85% symptom relief in small published series, though long-term data beyond five years are absent.
ChondroFiller or Arthrosamid for your kneeChondroFiller or Arthrosamid for your knee
ChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.ChondroFiller repairs focal cartilage defects via a collagen scaffold, and Arthrosamid provides cushioning by integrating into the synovial lining — because they target different anatomical structures, the MRI scan, not patient preference, determines which injection is appropriate.
Choosing a ChondroFiller Specialist in the UKChoosing a ChondroFiller Specialist in the UK
ChondroFiller is a CE-marked Class III medical device, requiring the same regulatory infrastructure as surgically implanted hardware: specialist ordering pipelines, cold-chain management, and clinical protocols that only a handful of UK centres currently maintain.ChondroFiller is a CE-marked Class III medical device, requiring the same regulatory infrastructure as surgically implanted hardware: specialist ordering pipelines, cold-chain management, and clinical protocols that only a handful of UK centres currently maintain.
What the ChondroFiller evidence actually showsWhat the ChondroFiller evidence actually shows
ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.ChondroFiller, a collagen scaffold, increases knee function scores by 30 points at three years — roughly double the clinical significance threshold — but no large independent randomised trial has been completed.
ChondroFiller duration vs hyaluronic acid and ArthrosamidChondroFiller duration vs hyaluronic acid and Arthrosamid
ChondroFiller's repair tissue outlasts the scaffold itself: the collagen dissolves within two years, but tissue built by the patient's own progenitor cells persists for three to five years.ChondroFiller's repair tissue outlasts the scaffold itself: the collagen dissolves within two years, but tissue built by the patient's own progenitor cells persists for three to five years.
Who qualifies for ChondroFiller injectionWho qualifies for ChondroFiller injection
ChondroFiller recruits the patient's own cells into a collagen scaffold placed within focal cartilage defects; candidacy requires mechanical joint stability and absence of widespread degeneration.ChondroFiller recruits the patient's own cells into a collagen scaffold placed within focal cartilage defects; candidacy requires mechanical joint stability and absence of widespread degeneration.
ChondroFiller injection vs PRP for cartilage repairChondroFiller injection vs PRP for cartilage repair
ChondroFiller fills focal cartilage defects with a collagen scaffold; PRP modulates inflammation in diffuse wear. MRI findings, not symptoms, determine which applies.ChondroFiller fills focal cartilage defects with a collagen scaffold; PRP modulates inflammation in diffuse wear. MRI findings, not symptoms, determine which applies.
ChondroFiller durability vs Arthrosamid and hyaluronic acidChondroFiller durability vs Arthrosamid and hyaluronic acid
ChondroFiller's collagen scaffold breaks down in six to twenty-four months, but the clinical benefit lasts one to five years or longer because the material recruits the patient's own progenitor cells to support cartilage repair, not to act as permanent filling.ChondroFiller's collagen scaffold breaks down in six to twenty-four months, but the clinical benefit lasts one to five years or longer because the material recruits the patient's own progenitor cells to support cartilage repair, not to act as permanent filling.
Choosing a ChondroFiller provider for knee defectsChoosing a ChondroFiller provider for knee defects
ChondroFiller is most plausible for focal knee cartilage defects seen on MRI, not widespread arthritis, with outpatient injection packages from about £3,000 and arthroscopic Liquid Cartilage pathways from about £9,800. Good candidates are assessed for defect size, containment, location and any subchondral bone involvement, because those factors shape the treatmentChondroFiller is most plausible for focal knee cartilage defects seen on MRI, not widespread arthritis, with outpatient injection packages from about £3,000 and arthroscopic Liquid Cartilage pathways from about £9,800. Good candidates are assessed for defect size, containment, location and any subchondral bone involvement, because those factors shape the treatment path.
10 results found in 2ms
  • ‹‹
  • 1
  • ››